Market revenue in 2023 | USD 2.6 million |
Market revenue in 2030 | USD 4.1 million |
Growth rate | 6.7% (CAGR from 2023 to 2030) |
Largest segment | Echocardiography |
Fastest growing segment | Radionuclide cardiac imaging |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Radionuclide cardiac imaging, Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging |
Key market players worldwide | Toshiba Corporation, Hologic Inc, Carestream Health - HCIS business, GE HealthCare Technologies Inc Common Stock, Siemens Healthineers AG ADR, Koninklijke Philips NV, Hitachi Ltd |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to non-invasive coronary imaging market will help companies and investors design strategic landscapes.
Echocardiography was the largest segment with a revenue share of 30.77% in 2023. Horizon Databook has segmented the Mexico non-invasive coronary imaging market based on radionuclide cardiac imaging, echocardiography, cardiac computed tomography, cardiac magnetic resonance imaging covering the revenue growth of each sub-segment from 2018 to 2030.
In Mexico, the substantial presence of major industry players, favorable governmental regulations, and investments from global market leaders have positioned the country as a significant contributor to cost-effective medical device manufacturing worldwide.
Leveraging skilled yet cost-effective manufacturing labor, geographic proximity to major markets, and robust infrastructure capabilities, Mexico has emerged as a prominent hub for the production of medical devices on a global scale.
The increasing prevalence of chronic disorders, such as cancer and neurological disorders, is one of the key factors likely to propel the market growth over the forecast period. For instance, according to data published by NIH, in July 2023, the cancer mortality rate in Mexico was 69.8/100,000 men and 62.5/100,000 women.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico non-invasive coronary imaging market , including forecasts for subscribers. This country databook contains high-level insights into Mexico non-invasive coronary imaging market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account